BaseLaunch is a world-leading accelerator
Healthcare accelerators recently came under the spotlight of technology platform Technorely. Its list of eight of the leading accelerators features BaselArea.swiss-operated BaseLaunch as one of only two outside North America.
Healthcare accelerators are one of the main reasons why startups in the sector have increased their capital funding. Now, Technorely has focused in a blog post on “the top healthcare accelerators” and delved into eight of them.
Six of the eight accelerators are in North America, with three each in the USA and Canada. The other two are in Europe: Bayer G4A, headquartered in Germany, and BaseLaunch, which is operated by the location promotion organization BaselArea.swiss.
BaseLaunch has two key aspects, according to the article – funding and mentoring. The program for healthcare startups is composed of two phases, runs for 15 months, and focuses on startups in therapeutics, diagnostics and vaccines. The article also highlights the benefits of the accelerator’s location in Basel: BaseLaunch gives entrepreneurs the opportunity to learn and work within the Basel region, a leading life sciences hub in Europe, it writes.
StartUp Health, Blueprint Health and Health Wildcatters from the USA and JLABS, MaRS Innovation and Interface Health from Canada are the North American accelerators included in the list.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More